The Effect of Age on Osteogenic and Adipogenic Differentiation Potential of Human Adipose Derived Stromal Stem Cells (hASCs) and the Impact of Stress Factors in the Course of the Differentiation Process

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Kornicka, Katarzyna ^a   Marycz, Krzysztof ^a,b   Tomaszewski, Krzysztof Andrzej ^c   Marędziak, Monika ^b,d   Smieszek, Agnieszka ^a,b  

^a WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^b WROCLAW RESEARCH CENTRE EIT   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; CYTOLOGY; DISEASE CONTROL; ENZYMES; GROWTH KINETICS; METABOLISM; NITRIC OXIDE; OXYGEN; STEM CELLS; TISSUE; TISSUE ENGINEERING;

ADIPOGENIC DIFFERENTIATIONS; CELLULAR MODIFICATION; DIFFERENTIATION PROCESS; MESENCHYMAL STEM CELL; REACTIVE OXYGEN SPECIES; REGENERATIVE MEDICINE; SUPEROXIDE DISMUTASE ACTIVITIES; THERAPEUTIC APPLICATION;

CELL ENGINEERING;

BETA GALACTOSIDASE; NITRIC OXIDE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; OSTEOCALCIN; OSTEOPONTIN; TP53 PROTEIN, HUMAN;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ADULT; AGE; AGED; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CELL AGING; CELL DIFFERENTIATION; CELL GROWTH; CELL KINETICS; CELL METABOLISM; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STROMA CELL; OXIDATIVE STRESS; SENESCENCE; UPREGULATION; ADIPOSE TISSUE; CELL CULTURE; CYTOLOGY; GENETICS; METABOLISM; MIDDLE AGED;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; AGE FACTORS; AGED; ALKALINE PHOSPHATASE; APOPTOSIS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN TYPE I; FEMALE; HUMANS; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; NITRIC OXIDE; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84938117661     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/309169     Document Type: Article

References (44)

1. J. A. Pérez-Simon, O. López-Villar, E. J. Andreu et al. , "Mesenchymalstem cells expanded in vitro with human serum forthe treatment of acute and chronic graft-versus-host disease:results of a phase I/II clinical trial, " Haematologica, vol. 96, no. 7, pp. 1072-1076, 2011.
2. M. S. Choudhery, M. Khan, R. Mahmood et al. , "Mesenchymalstem cells conditioned with glucose depletion augments theirability to repair-infarcted myocardium, " Journal of Cellular andMolecular Medicine, vol. 16, no. 10, pp. 2518-2529, 2012.
3. M. F. Pittenger, A. M. Mackay, S. C. Beck et al. , "Multilineagepotential of adult human mesenchymal stem cells, " Science, vol. 284, no. 5411, pp. 143-147, 1999.
4. C. C. I. Lee, F. Ye, andA. F. Tarantal, "Comparisonof growth anddifferentiation of fetal and adult rhesus monkey mesenchymalstem cells, " Stem Cells and Development, vol. 15, no. 2, pp. 209-220, 2006.
5. M. S. Choudhery, M. Badowski, A. Muise, and D. T. Harris, "Comparison of human mesenchymal stem cells derived fromadipose and cord tissue, " Cytotherapy, vol. 15, no. 3, pp. 330-343, 2013.
6. M. Abumaree, M. Al Jumah, R. A. Pace, and B. Kalionis, "Immunosuppressive properties of mesenchymal stem cells, "Stem Cell Reviews and Reports, vol. 8, no. 2, pp. 375-392, 2012.
7. P. Trivedi, N. Tray, T. Nguyen, N. Nigam, and G. I. Gallicano, "Mesenchymal stem cell therapy for treatment of cardiovasculardisease: helping people sooner or later, " StemCells and Development, vol. 19, no. 7, pp. 1109-1120, 2010.
8. S. E. Taylor, R. K. W. Smith, andP. D. Clegg, "Mesenchymal stemcell therapy in equine musculoskeletal disease: scientific fact orclinical fiction?" Equine Veterinary Journal, vol. 39, no. 2, pp. 172-180, 2007.
9. L. C. Amado, A. P. Saliaris, K. H. Schuleri et al. , "Cardiac repairwith intramyocardial injection of allogeneicmesenchymal stemcells after myocardial infarction, " Proceedings of the NationalAcademy of Sciences of the United States of America, vol. 102, no. 32, pp. 11474-11479, 2005.
10. H. Xin, Y. Li, L. H. Shen et al. , "Increasing tPa activity inastrocytes induced by multipotent mesenchymal stromal cellsfacilitate neurite outgrowth after stroke in the mouse, " PLoSONE, vol. 5, no. 2, Article ID e9027, 2010.
11. L. Biancone, S. Bruno, M. C. Deregibus, C. Tetta, and G. Camussi, "Therapeutic potential of mesenchymal stem cellderivedmicrovesicles, " Nephrology Dialysis Transplantation, vol. 27, no. 8, pp. 3037-3042, 2012.
12. Y. Zhu, T. Liu, K. Song, X. Fan, X. Ma, and Z. Cui, "Adiposederivedstem cell: a better stem cell than BMSC, " Cell Biochemistryand Function, vol. 26, no. 6, pp. 664-675, 2008.
13. S. Kern, H. Eichler, J. Stoeve, H. Klüter, and K. Bieback, "Comparative analysis of mesenchymal stem cells from bonemarrow, umbilical cord blood, or adipose tissue, " StemCells, vol. 24, no. 5, pp. 1294-1301, 2006.
14. A. mieszek, A. Donesz-Sikorska, J. Grzesiak, J. Krzak, andK. Marycz, "Biological effects of sol-gel derived ZrO2 andSiO2/ZrO2 coatings on stainless steel surface-in vitro modelusingmesenchymal stem cells, " Journal of Biomaterials Applications, vol. 29, no. 5, pp. 699-714, 2014.
15. K. Stenderup, J. Justesen, C. Clausen, and M. Kassem, "Agingis associated with decreased maximal life span and acceleratedsenescence of bone marrow stromal cells, " Bone, vol. 33, no. 6, pp. 919-926, 2003.
16. M. S. Choudhery, M. Badowski, A. Muise, J. Pierce, and D. T. Harris, "Donor age negatively impacts adipose tissue-derivedmesenchymal stem cell expansion and differentiation, " Journalof Translational Medicine, vol. 12, article 8, 2014.
17. T. Finkel and N. J. Holbrook, "Oxidants, oxidative stress and thebiology of ageing, " Nature, vol. 408, no. 6809, pp. 239-247, 2000.
18. B. Brüne, A. vonKnethen, and K. B. Sandau, "Nitric oxide (NO):an effector of apoptosis, " Cell Death and Differentiation, vol. 6, no. 10, pp. 969-975, 1999.
19. J. Grzesiak, K. Marycz, J. Czogala, K. Wrzeszcz, and J. Nicpon, "Comparison of behavior, morphology and morphometry ofequine and canine adipose derived mesenchymal stem cells inculture, " International Journal of Morphology, vol. 29, no. 3, pp. 1012-1017, 2011.
20. K. Marycz, A. Smieszek, J. Grzesiak, A. Donesz-Sikorska, and J. Krzak-Rós, "Application of bone marrow and adipose-derivedmesenchymal stem cells for testing the biocompatibility ofmetal-based biomaterials functionalized with ascorbic acid, "Biomedical Materials, vol. 8, no. 6, Article ID 065004, 2013.
21. M. Mardziak, K. Marycz, A. Smieszek, D. Lewandowski, andN. Y. Toker, "The influence of static magnetic fields on canineand equine mesenchymal stem cells derived from adiposetissue, " In Vitro Cellular and Developmental Biology-Animal, vol. 50, no. 6, pp. 562-571, 2014.
22. T. Chen, Y. Zhou, and W.-S. Tan, "Influence of lactic acidon the proliferation, metabolism, and differentiation of rabbitmesenchymal stem cells, " Cell Biology and Toxicology, vol. 25, no. 6, pp. 573-586, 2009.
23. V. Roth, http://www. doubling-time. com/compute. php.
24. P. Chomczynski and N. Sacchi, "Single-step method of RNAisolation by acid guanidinium thiocyanate-phenol-chloroformextraction, " Analytical Biochemistry, vol. 162, no. 1, pp. 156-159, 1987.
25. D. Bös and R. K. von Weizsäcker, "Economic consequences ofan aging population, " European Economic Review, vol. 33, no. 2-3, pp. 345-354, 1989.
26. WHO, Comparative Quantification of Health Risks, WorldHealth Organization, Geneva, Switzerland, 2004.
27. J. V. Bannister, W. H. Bannister, and G. Rotilio, "Aspects of thestructure, function, and applications of superoxide dismutase, "CRC Critical Reviews in Biochemistry, vol. 22, no. 2, pp. 111-180, 1987.
28. M. Zhu, E. Kohan, J. Bradley, M. Hedrick, P. Benhaim, andP. Zuk, "The effect of age on osteogenic, adipogenic andproliferative potential of female adipose-derived stem cells, "Journal of Tissue Engineering and Regenerative Medicine, vol. 3, no. 4, pp. 290-301, 2009.
29. B. M. Schipper, K. G. Marra, W. Zhang, A. D. Donnenberg, andJ. P. Rubin, "Regional anatomic and age effects on cell functionof human adipose-derived stem cells, " Annals of Plastic Surgery, vol. 60, no. 5, pp. 538-544, 2008.
30. A. Stolzing, E. Jones, D. McGonagle, and A. Scutt, "Age-relatedchanges in human bone marrow-derived mesenchymal stemcells: consequences for cell therapies, "Mechanisms ofAgeing andDevelopment, vol. 129, no. 3, pp. 163-173, 2008.
31. S. Zhou, J. S. Greenberger, M. W. Epperly et al. , "Age-relatedintrinsic changes in human bone-marrow-derived mesenchymalstem cells and their differentiation to osteoblasts, " AgingCell, vol. 7, no. 3, pp. 335-343, 2008.
32. E. C. Filippi-Chiela, M. M. Oliveira, B. Jurkovski, S. M. Callegari-Jacques, V. D. da Silva, and G. Lenz, "Nuclear morphometricanalysis (NMA): screening of senescence, apoptosisand nuclear irregularities, " PLoS ONE, vol. 7, no. 8, Article IDe42522, 2012.
33. P. A. Zuk, M. Zhu, P. Ashjian et al. , "Human adipose tissue is asource of multipotent stem cells, " Molecular Biology of the Cell, vol. 13, no. 12, pp. 4279-4295, 2002.
34. C.-T. Chen, Y.-R. V. Shih, T. K. Kuo, O. K. Lee, and Y.-H. Wei, "Coordinated changes of mitochondrial biogenesisand antioxidant enzymes during osteogenic differentiation ofhuman mesenchymal stem cells, " Stem Cells, vol. 26, no. 4, pp. 960-968, 2008.
35. Z. S. Xiao, L. D. Quarles, Q. Q. Chen et al. , "Effect of asymmetricdimethylarginine on osteoblastic differentiation, " Kidney International, vol. 60, no. 5, pp. 1699-1704, 2001.
36. C. Geula, C.-K. Wu, D. Saroff, A. Lorenzo, M. Yuan, and B. A. Yankner, "Aging renders the brain vulnerable to amyloid betaproteinneurotoxicity, " Nature Medicine, vol. 4, no. 7, pp. 827-831, 1998.
37. L. Lenchik, T. C. Register, F.-C. Hsu et al. , "Adiponectin as anovel determinant of bone mineral density and visceral fat, "Bone, vol. 33, no. 4, pp. 646-651, 2003.
38. P. Meunier, J. Aaron, C. Edouard, and G. Vignon, "Osteoporosisand the replacement of cell populations of the marrow byadipose tissue. A quantitative study of 84 iliac bone biopsies. , "Clinical Orthopaedics and Related Research, vol. 80, pp. 147-154, 1971.
39. S. E. Ross, N. Hemati, K. A. Longo et al. , "Inhibition ofadipogenesis by Wnt signaling, " Science, vol. 289, no. 5481, pp. 950-953, 2000.
40. C. Bruedigam, M. Eijken, M. Koedam et al. , "A new conceptunderlying stem cell lineage skewing that explains the detrimentaleffects of thiazolidinediones on bone, " Stem Cells, vol. 28, no. 5, pp. 916-927, 2010.
41. M. Berdasco and M. Esteller, "Hot topics in epigenetic mechanismsof aging: 2011, " Aging Cell, vol. 11, no. 2, pp. 181-186, 2012.
42. R. F. Thompson, G. Atzmon, C. Gheorghe et al. , "Tissue-specificdysregulation of DNAmethylation in aging, " Aging Cell, vol. 9, no. 4, pp. 506-518, 2010.
43. X. Yan, S. Ehnert, M. Culmes et al. , "5-azacytidine improvesthe osteogenic differentiation potential of aged human adiposederivedmesenchymal stem cells by DNA demethylation, " PLoSONE, vol. 9, no. 3, Article ID e90846, 2014.
44. T.-M. Lin, J.-L. Tsai, S.-D. Lin, C.-S. Lai, and C.-C. Chang, "Accelerated growth and prolonged lifespan of adipose tissuederivedhuman mesenchymal stem cells in a medium usingreduced calcium and antioxidants, " Stem Cells and Development, vol. 14, no. 1, pp. 92-102, 2005.